STAAR Surgical Company (STAA)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 313,901 | 322,415 | 284,391 | 230,472 | 163,460 |
| Total current assets | US$ in thousands | 367,940 | 365,269 | 311,973 | 271,411 | 216,418 |
| Total current liabilities | US$ in thousands | 70,306 | 65,036 | 51,716 | 48,802 | 41,236 |
| Working capital turnover | 1.05 | 1.07 | 1.09 | 1.04 | 0.93 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $313,901K ÷ ($367,940K – $70,306K)
= 1.05
The working capital turnover ratio for STAAR Surgical Company has shown a gradual improvement over the last five years, increasing from 0.93 in December 2020 to 1.05 in December 2024. This indicates that the company's efficiency in utilizing its working capital to generate sales has been on an upward trend.
In 2021, the ratio saw a significant jump to 1.04, signaling an improvement in the company's ability to convert its working capital into revenue. Subsequently, in 2022, the ratio further increased to 1.09, showcasing an even stronger performance in the management of working capital.
Although there was a slight dip in the ratio in 2023 to 1.07, it remained relatively high, indicating that the company continued to effectively leverage its working capital to support its operational activities. In 2024, the ratio stood at 1.05, suggesting that STAAR Surgical Company maintained a solid level of efficiency in utilizing its working capital to drive sales.
Overall, the increasing trend in the working capital turnover ratio demonstrates the company's ability to efficiently manage its working capital resources and generate revenue, which is a positive sign for its operational performance and financial health.
Peer comparison
Dec 31, 2024